News

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...
Ready to transform your body? It's possible with this program's personalized care, telehealth consultations, and semaglutide ...
Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.
Through transparent pricing, unlimited provider communication, and a lab-driven approach to dosage personalization, Sesame is making weight loss with compounded semaglutide more achievable for ...
Many Americans are taking GLP1 medications, which include weight loss and diabetes medications Ozempic and Wegovy.
Ozempic, originally for type 2 diabetes, has surged in popularity in North America as a weight-loss solution, sparking a ...
A new generation of oral weight loss medications could transform the fight against obesity and diabetes in low- and ...
The lower rating came from HSBC, which cited too much optimism around its new weight-loss pill, and the strength of Novo ...
Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Novo Nordisk partners with telehealth ...
Through transparent pricing, unlimited provider communication, and a lab-driven approach to dosage personalization, Sesame is making weight loss with compounded semaglutide more achievable for ...
Hims & Hers partners with Novo Nordisk to offer Wegovy access online with clinical support, expanding its weight loss care and revenue strategy.